iPSC-neuron Based Phenotypic Screening

804 views

|

April 11, 2019

  • Share
  • Dr Darren Cawkill, Project Director, Apollo Therapeutics, outlines the patient-derived iPSC-neuron based phenotypic screening strategy and its advantages within drug discovery.

    Drug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.